Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hald

Showing results (1081-1090 of 1,101) with videos related to

Pageof 111
Sort By:
Frontiers in Oncology|March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative NeoplasmsJacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Plos One|December 4, 2015
Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne DiseaseBrecht Devleesschauwer, Juanita A Haagsma, Frederick J Angulo, et al.
Viruses|June 27, 2024
The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 VaccinesSebastian Rask Hamm, Josefine Amalie Loft, Laura Pérez-Alós, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 4, 2022
Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severityNita Katarina Frifelt Wienholtz, Jacob P Thyssen, Casper Emil Christensen, et al.
Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF<sup>®</sup>09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.
Frontiers in Microbiology|February 20, 2025
Source attribution of human <i>Campylobacter</i> infection: a multi-country model in the European UnionCecilie Thystrup, Maja Lykke Brinch, Clementine Henri, et al.
Communications Medicine|September 14, 2022
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patientsRebecka Svanberg, Cameron MacPherson, Adrian Zucco, et al.
Frontiers in Immunology|January 30, 2023
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infectionOmid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, et al.
Communications Medicine|April 16, 2024
Erratum: Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patientsRebecka Svanberg, Cameron MacPherson, Adrian Zucco, et al.
BMC Women'S Health|October 7, 2018
The randomised uterine septum transsection trial (TRUST): design and protocolJ F W Rikken, C R Kowalik, M H Emanuel, et al.
Pageof 111

Showing results (1081-1090 of 1,101) with videos related to

Sort By:
Pageof 111
Frontiers in Oncology|March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative NeoplasmsJacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Plos One|December 4, 2015
Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne DiseaseBrecht Devleesschauwer, Juanita A Haagsma, Frederick J Angulo, et al.
Viruses|June 27, 2024
The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 VaccinesSebastian Rask Hamm, Josefine Amalie Loft, Laura Pérez-Alós, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 4, 2022
Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severityNita Katarina Frifelt Wienholtz, Jacob P Thyssen, Casper Emil Christensen, et al.
Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF<sup>®</sup>09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.
Frontiers in Microbiology|February 20, 2025
Source attribution of human <i>Campylobacter</i> infection: a multi-country model in the European UnionCecilie Thystrup, Maja Lykke Brinch, Clementine Henri, et al.
Communications Medicine|September 14, 2022
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patientsRebecka Svanberg, Cameron MacPherson, Adrian Zucco, et al.
Frontiers in Immunology|January 30, 2023
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infectionOmid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, et al.
Communications Medicine|April 16, 2024
Erratum: Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patientsRebecka Svanberg, Cameron MacPherson, Adrian Zucco, et al.
BMC Women'S Health|October 7, 2018
The randomised uterine septum transsection trial (TRUST): design and protocolJ F W Rikken, C R Kowalik, M H Emanuel, et al.
Pageof 111